S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:GHRS

GH Research (GHRS) Stock Price, News & Analysis

$10.66
-0.05 (-0.47%)
(As of 03/28/2024 ET)
Today's Range
$10.59
$10.87
50-Day Range
$5.63
$11.09
52-Week Range
$5.05
$14.64
Volume
44,423 shs
Average Volume
141,689 shs
Market Capitalization
$554.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$39.50

GH Research MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
270.5% Upside
$39.50 Price Target
Short Interest
Bearish
4.47% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.96) to ($1.17) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.98 out of 5 stars

Medical Sector

726th out of 938 stocks

Pharmaceutical Preparations Industry

327th out of 423 stocks

GHRS stock logo

About GH Research Stock (NASDAQ:GHRS)

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies to treat psychiatric and neurological disorders. The company develops 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable mebufotenin product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an intravenous mebufotenin product candidate; and GH003, an intranasal mebufotenin product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

GHRS Stock Price History

GHRS Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
GH Research PLC GHRS
H.C. Wainwright Sticks to Their Buy Rating for GH Research (GHRS)
See More Headlines
Receive GHRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GH Research and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
3/28/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GHRS
Fax
N/A
Employees
32
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$39.50
High Stock Price Target
$40.00
Low Stock Price Target
$39.00
Potential Upside/Downside
+270.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-35,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.94 per share

Miscellaneous

Free Float
30,384,000
Market Cap
$554.64 million
Optionable
Optionable
Beta
0.79
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Florian Schonharting M.Sc. (Econ) (Age 55)
    Co-Founder & Non-Executive Chairman of the Board
  • Dr. Theis Terwey M.D. (Age 48)
    Co-Founder & CEO
  • Mr. Magnus Halle (Age 27)
    Co-Founder & MD of Ireland
  • Ms. Julie Ryan F.C.A. (Age 38)
    Vice President of Finance
  • Mr. Aaron Cameron M.B.A. (Age 38)
    Chief Operating Officer
  • Mr. Naoise Gaffney
    VP & Head of Intellectual Property

GHRS Stock Analysis - Frequently Asked Questions

Should I buy or sell GH Research stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GH Research in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GHRS shares.
View GHRS analyst ratings
or view top-rated stocks.

What is GH Research's stock price target for 2024?

2 brokerages have issued twelve-month price objectives for GH Research's shares. Their GHRS share price targets range from $39.00 to $40.00. On average, they expect the company's stock price to reach $39.50 in the next twelve months. This suggests a possible upside of 270.5% from the stock's current price.
View analysts price targets for GHRS
or view top-rated stocks among Wall Street analysts.

How have GHRS shares performed in 2024?

GH Research's stock was trading at $5.80 at the start of the year. Since then, GHRS stock has increased by 83.8% and is now trading at $10.66.
View the best growth stocks for 2024 here
.

When is GH Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our GHRS earnings forecast
.

How were GH Research's earnings last quarter?

GH Research PLC (NASDAQ:GHRS) released its quarterly earnings results on Thursday, February, 29th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.01.

What ETFs hold GH Research's stock?

ETFs with the largest weight of GH Research (NASDAQ:GHRS) stock in their portfolio include AdvisorShares Psychedelics ETF (PSIL).iShares MSCI Ireland ETF (EIRL).

When did GH Research IPO?

GH Research (GHRS) raised $150 million in an IPO on Friday, June 25th 2021. The company issued 10,000,000 shares at $14.00-$16.00 per share.

Who are GH Research's major shareholders?

GH Research's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BVF Inc. IL (20.59%), Verition Fund Management LLC (0.00%), Mirae Asset Global Investments Co. Ltd. (0.00%), Citadel Advisors LLC (0.19%), AdvisorShares Investments LLC (0.00%) and Barclays PLC (0.06%).

How do I buy shares of GH Research?

Shares of GHRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GHRS) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners